Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

ZTlido Patch for Post-Shingles Pain Launching Soon

ZTlido Patch for Post-Shingles Pain Launching Soon

By

The non-aqueous adhesive patch requires 36mg per topical system to achieve the same therapeutic dose as Lidoderm (lidocaine 5%) which contains 700mg per patch.

Cassipa Approved as Maintenance Treatment for Opioid Dependence

Cassipa Approved as Maintenance Treatment for Opioid Dependence

By

Cassipa combines buprenorphine, an opioid (partial agonist-antagonist), and naloxone, an opioid antagonist.

First-in-Class Non-Opioid for Post-Surgical Pain Gets Breakthrough Tx Designation

First-in-Class Non-Opioid for Post-Surgical Pain Gets Breakthrough Tx Designation

By

CA-008 is given as a single local injection and works by selectively desensitizing pain-conducting nerve fibers without causing numbness or weakness

Ajovy Injection Approved for Migraine Prevention in Adults

Ajovy Injection Approved for Migraine Prevention in Adults

By

The primary efficacy endpoint was the mean change from baseline in the monthly average number of headache days of at least moderate severity during the 3-month treatment period.

Four Homeopathic Products Recalled Due to Possible Microbial Contamination

Four Homeopathic Products Recalled Due to Possible Microbial Contamination

By

Tests revealed Neuroveen to be contaminated with Staphylococcus saprophyticus and Burkholderia cepacia. Compulsin was also tested and found to contain B. cepacia.

More Articles by Da Hee Han, PharmD

Sign Up for Free e-Newsletters